Dicerna Announces Proof Of Concept For DCR-PHXC In The Treatment Of Primary Hyperoxaluria; Initial Six-Week Data Show Significant And Sustained Reduction In Urinary Oxalate Levels, Detailed Readout Expected In Q4
Benzinga Newsdesk